Keiko Obata - Concepedia

Author

Keiko Obata

Kindai University

Also Known As

K OBATA, K Obata, K. Obata, KENTA OBATA, Keiko Obata

Publications

527

Citations

H-Index

Concepts

All Affiliations

Kindai University

About

Keiko Obata is an author at Kindai University specializing in medicine, cell biology, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	355
2	Cell Biology	4	4	340
3	Natural Sciences	3	3	330
4	Biochemistry	1	1	274
5	Cellular Physiology	1	1	274

Keiko Obata

Publications

409

Citations

H-Index

Page 1

	Year	Citations
Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1. Akihiro Inoue, Keiko Obata, Kimio Akagawa Journal of Biological Chemistry Molecular BiologyAntigen ProcessingCellular NeurobiologyCellular PhysiologyHpc-1 Antigen	1992	274
Fusion Protein of Retinoic Acid Receptor α with Promyelocytic Leukemia Protein or Promyelocytic Leukemia Zinc Finger Protein Recruits N-CoR-TBLR1 Corepressor Complex to Repress Transcription in Vivo Akihiro Tomita, Daniel R. Buchholz, Keiko Obata, Journal of Biological Chemistry	2003	44
Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma Keiko Obata, Hiroaki Hiraga, Takayuki Nojima, Genes Chromosomes and Cancer Molecular CharacterizationEwing SarcomaTumor HeterogeneityNatural SciencesGenomic Breakpoint Junction	1999	41
Human Biotin-Containing Subunit of 3-Methylcrotonyl-CoA Carboxylase Gene (MCCA): cDNA Sequence, Genomic Organization, Localization to Chromosomal Band 3q27, and Expression Keiko Obata, Takayuki Fukuda, Riyo Morishita, Genomics ChromatinHuman Biotin-containing SubunitNatural SciencesGeneticsGene Structure	2001	15
Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion Akira Hamada, Kenichi Suda, Masaya Nishino, Journal of Thoracic Oncology Secondary MutationsMedicineGeneticsGenetic DisorderGenetic Mechanism	2023	14
Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer Kenichi Suda, Isao Murakami, Keiko Obata, Lung Cancer Systems BiologySpatial HeterogeneityMedicineReceptor Tyrosine KinaseBronchial Neoplasm	2020	11
Inter- and Intratumor Heterogeneity of EGFR Compound Mutations in Non–Small Cell Lung Cancers: Analysis of Five Cases Kenichi Suda, Kazuko Sakai, Keiko Obata, Clinical Lung Cancer	2020	10

Page 1